| 000 | 01724 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250517193757.0 | ||
| 264 | 0 | _c20180924 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009742.2017.1376110 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGlintborg, B | |
| 245 | 0 | 0 |
_aDrug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _c09 2018 |
||
| 300 |
_a418-421 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xblood |
| 650 | 0 | 4 |
_aArthritis _xblood |
| 650 | 0 | 4 | _aDenmark |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aKringelbach, T | |
| 700 | 1 | _aBolstad, N | |
| 700 | 1 | _aWarren, D J | |
| 700 | 1 | _aEng, G | |
| 700 | 1 | _aSørensen, I J | |
| 700 | 1 | _aLoft, A G | |
| 700 | 1 | _aHendricks, O | |
| 700 | 1 | _aHansen, Imj | |
| 700 | 1 | _aLinauskas, A | |
| 700 | 1 | _aNordin, H | |
| 700 | 1 | _aKristensen, S | |
| 700 | 1 | _aLindegaard, H | |
| 700 | 1 | _aJensen, D V | |
| 700 | 1 | _aGoll, G L | |
| 700 | 1 | _aHøgdall, E | |
| 700 | 1 | _aGehin, J | |
| 700 | 1 | _aEnevold, C | |
| 700 | 1 | _aNielsen, C H | |
| 700 | 1 | _aKrogh, N S | |
| 700 | 1 | _aJohansen, J S | |
| 700 | 1 | _aHetland, M L | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 47 _gno. 5 _gp. 418-421 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009742.2017.1376110 _zAvailable from publisher's website |
| 999 |
_c27957206 _d27957206 |
||